Advanced Breast Cancer
09
Sep
A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab (MK...
Early Breast Cancer
23
Jul
A Phase III, Randomized, open labelled, multicenter study evaluating the efficacy and safety of adjuvant giredestrant compared with p...